Related Experiment Video
Updated: Sep 14, 2025

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
C20orf27 promotes hepatocellular carcinoma progression via NT5E
Yu He1,2, Wen Zhang1, Ming Chang3
1School of Medicine, Southern University of Science and Technology, Shenzhen, 518055, Guangdong, China.
This study identifies C20orf27 as a key driver of liver cancer. Upregulation of C20orf27 and NT5E indicates a poor prognosis for hepatocellular carcinoma patients.
Area of Science:
- Molecular oncology
- Hepatocellular carcinoma research
Background:
- Liver cancer remains a leading cause of cancer mortality globally.
- Effective therapeutic targets for liver cancer are limited, necessitating further research into novel molecular mechanisms.
- The function of C20orf27, a gene on human chromosome 20, is not well understood.
Purpose of the Study:
- To investigate the role of C20orf27 in liver cancer progression.
- To identify downstream targets and potential biomarkers associated with C20orf27 in hepatocellular carcinoma (HCC).
- To explore the prognostic significance of the C20orf27/NT5E axis in HCC.
Main Methods:
- Analysis of C20orf27 expression in liver cancer samples.
- Gain- and loss-of-function experiments to assess C20orf27's impact on cell proliferation and migration.
- RNA sequencing, bioinformatics analysis, and immunohistochemistry to identify and validate downstream targets and clinical associations.
Main Results:
- C20orf27 was found to be upregulated in liver cancer tissues.
- C20orf27 promoted HCC cell proliferation and migration by regulating cell cycle proteins (MDM2, PCNA, Cyclin E1, CDK2, p-Rb).
- NT5E was identified as a direct downstream target of C20orf27, and their combined high expression correlated with poorer patient survival.
Conclusions:
- C20orf27 plays a critical role in promoting hepatocellular carcinoma progression.
- The C20orf27/NT5E axis is a significant factor in HCC development and patient prognosis.
- C20orf27 and NT5E represent potential novel therapeutic targets and prognostic biomarkers for liver cancer.
More Related Videos
06:38An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
Related Concept Videos
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Mechanisms of Retrovirus-induced Cancers